Literature DB >> 25808229

The microbiota in inflammatory bowel disease.

Donal Sheehan1, Carthage Moran, Fergus Shanahan.   

Abstract

This review explores our current understanding of the complex interaction between environmental risk factors, genetic traits and the development of inflammatory bowel disease. The primacy of environmental risk factors is illustrated by the rapid increase in the incidence of the disease worldwide. We discuss how the gut microbiota is the proximate environmental risk factor for subsequent development of inflammatory bowel disease. The evolving fields of virome and mycobiome studies will further our understanding of the full potential of the gut microbiota in disease pathogenesis. Manipulating the gut microbiota is a promising therapeutic avenue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808229     DOI: 10.1007/s00535-015-1064-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  133 in total

1.  Phenotype of inflammatory bowel disease at diagnosis in the Netherlands: a population-based inception cohort study (the Delta Cohort).

Authors:  Veerle J A A Nuij; Zuzana Zelinkova; Marno C M Rijk; Ruud Beukers; Rob J T Ouwendijk; Rutger Quispel; Antonie J P van Tilburg; Thjon J Tang; Hermen Smalbraak; Karlien F Bruin; Flordeliz Lindenburg; Laurent Peyrin-Biroulet; C Janneke van der Woude
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

Review 2.  Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases.

Authors:  Charles N Bernstein; Fergus Shanahan
Journal:  Gut       Date:  2008-05-30       Impact factor: 23.059

3.  Measures of obesity and risk of Crohn's disease and ulcerative colitis.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

4.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

Review 5.  Exploiting gut bacteriophages for human health.

Authors:  Marion Dalmasso; Colin Hill; R Paul Ross
Journal:  Trends Microbiol       Date:  2014-03-20       Impact factor: 17.079

6.  Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease.

Authors:  Jason W Harper; Mika N Sinanan; Timothy L Zisman
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort.

Authors:  Euphemia Leung; Jiwon Hong; Alan G Fraser; Tony R Merriman; Prakash Vishnu; Geoffrey W Krissansen
Journal:  Immunol Cell Biol       Date:  2006-04       Impact factor: 5.126

9.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Authors:  Xochitl C Morgan; Timothy L Tickle; Harry Sokol; Dirk Gevers; Kathryn L Devaney; Doyle V Ward; Joshua A Reyes; Samir A Shah; Neal LeLeiko; Scott B Snapper; Athos Bousvaros; Joshua Korzenik; Bruce E Sands; Ramnik J Xavier; Curtis Huttenhower
Journal:  Genome Biol       Date:  2012-04-16       Impact factor: 13.583

10.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.

Authors:  Benoit Chassaing; Omry Koren; Julia K Goodrich; Angela C Poole; Shanthi Srinivasan; Ruth E Ley; Andrew T Gewirtz
Journal:  Nature       Date:  2015-02-25       Impact factor: 49.962

View more
  83 in total

Review 1.  Indole compounds may be promising medicines for ulcerative colitis.

Authors:  Shinya Sugimoto; Makoto Naganuma; Takanori Kanai
Journal:  J Gastroenterol       Date:  2016-05-09       Impact factor: 7.527

Review 2.  A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.

Authors:  Takanori Kanai; Yohei Mikami; Atsushi Hayashi
Journal:  J Gastroenterol       Date:  2015-05-05       Impact factor: 7.527

Review 3.  Chemical signaling between gut microbiota and host chromatin: What is your gut really saying?

Authors:  Kimberly A Krautkramer; Federico E Rey; John M Denu
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

4.  Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.

Authors:  Atsushi Nishida; Hirotsugu Imaeda; Masashi Ohno; Osamu Inatomi; Shigeki Bamba; Mitsushige Sugimoto; Akira Andoh
Journal:  J Gastroenterol       Date:  2016-10-11       Impact factor: 7.527

5.  Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.

Authors:  Kenichi Yoshikawa; Chie Kurihara; Hirotaka Furuhashi; Takeshi Takajo; Koji Maruta; Yuichi Yasutake; Hirokazu Sato; Kazuyuki Narimatsu; Yoshikiyo Okada; Masaaki Higashiyama; Chikako Watanabe; Shunsuke Komoto; Kengo Tomita; Shigeaki Nagao; Soichiro Miura; Hisao Tajiri; Ryota Hokari
Journal:  J Gastroenterol       Date:  2016-04-13       Impact factor: 7.527

Review 6.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 7.  Communicating systems in the body: how microbiota and microglia cooperate.

Authors:  Daniel Erny; Anna Lena Hrabě de Angelis; Marco Prinz
Journal:  Immunology       Date:  2016-08-24       Impact factor: 7.397

Review 8.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

9.  Gut Microbiota Dysbiosis Enhances Migraine-Like Pain Via TNFα Upregulation.

Authors:  Yuanyuan Tang; Sufang Liu; Hui Shu; Lora Yanagisawa; Feng Tao
Journal:  Mol Neurobiol       Date:  2019-08-04       Impact factor: 5.590

Review 10.  Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Nancy Fu; Titus Wong
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.